Based on the above results in vitro, in vivo, and ex vivo, we proposed a novel molecular mechanism for Notch1 in regulating cell proliferation and a new therapeutic paradigm targeting the ANXA1‐Notch1 signaling of human AML as shown in Figure7. Here, NOTCH1 is linked to acute myeloid leukemia.